DV
Dividend Vision

IDYA — IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA)

Total return is 224.4% over the past 7.2 years, 18.2 points ahead of SPY at 206.2%. Its deepest 1-year drawdown was 27.1%.

IDEAYA Biosciences is a single-stock equity security focused on clinical-stage biopharmaceutical development. The company does not currently pay distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This security appeals primarily to growth-oriented investors interested in the biotech sector's development-stage opportunities.

IDYA key facts

Asset type
Stock
Asset class
Equity
Inception date
05/23/2019
Distribution frequency
None
Last close
$36.30
Market cap
$3,531,359,744
Average volume
435200.0
Beta
-0.091
Payout ratio
0.0
Forward P/E
4.649
EPS
$-1.91